Skip to main content
Deepak Nitrite Limited logo

Deepak Nitrite Limited — Investor Relations & Filings

Ticker · DEEPAKNTR ISIN · INE288B01029 LEI · 335800FKRXU8C9F4PI09 BSE.NS Manufacturing
Filings indexed 1,548 across all filing types
Latest filing 2020-11-04 Regulatory Filings
Country IN India
Listing BSE.NS DEEPAKNTR

About Deepak Nitrite Limited

https://www.godeepak.com

Deepak Nitrite Limited is a multi-product chemical intermediary manufacturer. The company operates through four primary business segments: Basic Chemicals, Fine & Specialty Chemicals, Performance Products, and Phenolics. Its product portfolio includes sodium nitrite, sodium nitrate, nitro-toluenes, fuel additives, and optical brightening agents used in paper, detergent, and textile industries. Through its subsidiary, Deepak Phenolics Limited, it is a major producer of phenol, acetone, and isopropyl alcohol. The company serves diverse end-use industries such as agrochemicals, pharmaceuticals, rubber, colorants, and laminates. It maintains a strong focus on research and development and process innovation to ensure high-quality chemical intermediates and cost-efficient production.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited, informing about the schedule of a Q2 and H1 FY2021 earnings conference call. It references the financial results for the quarter and half year ended September 30, 2020, and provides details for the upcoming conference call including timing, participants, and dial-in information. The document does not contain actual financial data or detailed financial statements but is an announcement about the earnings call event. According to the classification rules, announcements about conference calls are classified as Call Transcript (CT) only if they contain the full transcript. Since this document is only an announcement of the conference call schedule and details, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. The document length is short (2879 characters), and it is not a report itself but an announcement of an event related to financial results.
2020-11-04 English
Schedule of Q2 & H1 FY2021 Earnings Conference Call
Regulatory Filings Classification · 95% confidence The document is a notification about the schedule of an earnings conference call for Q2 and H1 FY2021 financial results. It includes details about the call timing, participants, and dial-in information. It does not contain actual financial data or analysis but serves as an announcement for the upcoming earnings call. According to the filing definitions, a full transcript of the call would be classified as a Call Transcript (CT), but this document is only an announcement of the call itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. The document length is short (2902 characters), supporting that it is an announcement rather than a full report or transcript.
2020-11-04 English
Updates
Regulatory Filings
2020-11-02 English
Publications of Unaudited Financial Results
Regulatory Filings
2020-11-02 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Q2 & H1 FY2021 – INVESTOR COMMUNICATION' and contains detailed financial results for the second quarter and first half of fiscal year 2021. It includes consolidated and standalone revenues, EBITDA, PAT, EPS, segmental performance, and outlook commentary from the Chairman & Managing Director. The document provides comprehensive financial data and analysis for a period shorter than a full fiscal year (quarter and half-year). It is not merely an announcement or a brief summary but a detailed report with substantive financial information. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-10-30 English
Q2 & H1 FY2021-Investor Communication
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Q2 & H1 FY2021 – INVESTOR COMMUNICATION' and contains detailed financial results for the second quarter and first half of fiscal year 2021. It includes consolidated and standalone revenues, EBITDA, PAT, EPS, segmental performance, and outlook commentary from the Chairman & Managing Director. The document provides comprehensive financial data and analysis for a period shorter than a full fiscal year (quarter and half-year). It is not merely an announcement or a brief summary but a detailed report with substantive financial information. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-10-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.